Published 2024
| Version v1
Journal article
Use of nivolumab in solid tumours
Creators
- 1. Onkologicka klinika SZU, F. D. Roosevelta Fakultna nemocnica s poliklinikou, Banska Bystrica (Slovakia)
Description
Nivolumab is one of the revolutionary substances in oncology. It represents a breakthrough form of immunotherapy redefining the paradigm of the fight against malignancies. It activates the endogenous mechanisms of the immune system with the aim of selective recognition and elimination of malignant cells. It is currently used in a wide range of solid or hematological diagnoses. (author)
Additional details
Additional titles
- Original title (Slovak)
- Vyuzitie nivolumabu pri solidnych nadoroch
Publishing Information
- Journal Title
- Onkologia (Bratislava)
- Journal Volume
- 19
- Journal Issue
- 4
- Journal Page Range
- p. 274-278
- ISSN
- 1336-8176
INIS
- Country of Publication
- Slovakia
- Country of Input or Organization
- Slovakia
- INIS RN
- 55106384
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS;
- Descriptors DEI
- CHEMOTHERAPY; IMMUNOTHERAPY; MELANOMAS
- Descriptors DEC
- CARCINOMAS; DISEASES; EPITHELIOMAS; MEDICINE; NEOPLASMS; THERAPY
Optional Information
- Notes
- 39 refs., 1 fig., 2 tab.